NCT05381701

Brief Summary

Evaluation of atelectasis that may be caused by different flow rate anesthesia applications during the operation with lung ultrasound score.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 21, 2022

Completed
28 days until next milestone

First Posted

Study publicly available on registry

May 19, 2022

Completed
Last Updated

May 19, 2022

Status Verified

May 1, 2022

Enrollment Period

12 months

First QC Date

April 21, 2022

Last Update Submit

May 18, 2022

Conditions

Keywords

Lung Ultrasound ScoreMinimal Flow AnesthesiaAtelectasis

Outcome Measures

Primary Outcomes (1)

  • assessment of lung ultrasound score

    Effect of different flow anesthesia on lung ultrasound score

    Change from Baseline and 30 minute after emergence

Study Arms (3)

Group I

Minimal Flow Anesthesia (0.25L/dk oxygen, 0,25 L/min air)

Procedure: Lung Ultrasound Score

Group II

Low Flow Anesthesia (0.5L/dk oxygen, 0,5 L/min air)

Procedure: Lung Ultrasound Score

Group III

Medium Flow Anesthesia (1L/dk oxygen, 1 L/min air

Procedure: Lung Ultrasound Score

Interventions

Measuring the atelectasis area by ultrasound guidance from 12 different regions of the lung

Group IGroup IIGroup III

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

ASA I-II septoplasty and rhinoplasty patients aged 18-65 years

You may qualify if:

  • operation time 2-5 hours
  • elective septoplasty and rhinoplasty
  • ASA I-II

You may not qualify if:

  • morbid obesity
  • malignant hyperthermia
  • opioid sensitivity
  • alcohol or drug addiction
  • congestive heart failure
  • chronic obstructive pulmonary disease
  • coronary artery disease
  • anemia
  • liver and kidney diseases
  • pregnancy
  • breast-feeding
  • history of allergy to drugs used

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zonguldak Bülent Ecevit University Faculty of Medicine

Zonguldak, Kozlu, 67600, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pulmonary Atelectasis

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesiologist

Study Record Dates

First Submitted

April 21, 2022

First Posted

May 19, 2022

Study Start

January 1, 2021

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

May 19, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will share

Locations